CLEAR ALL
Exploring the bright future of psychedelics, Thomas B. Roberts, Ph.D., reveals how new uses for entheogens will enrich individuals as well as society as a whole. With contributions from Charles Grob, M.D., and Roger N. Walsh, M.D., Ph.D.
1
In the 1950s a group of pioneering psychiatrists showed that hallucinogenic drugs had therapeutic potential, but the research was halted as part of the backlash against the hippy counterculture.
In this webinar, Dr. Sanjay Mathew will review the history of ketamine for the treatment of serious depressive disorders and other similar treatments in development.
In an important step toward medical approval, MDMA, the illegal drug popularly known as Ecstasy or Molly, was shown to bring relief to those suffering from severe post-traumatic stress disorder when paired with talk therapy.
2
Here he describes the process of setting up a program to research the psychedelic drug, DMT, at the University of New Mexico. It took two years to obtain the required permissions, as there had been a twenty year hiatus in psychedelic research on human subjects.
A recent study found that even a single positive psychedelic experience may ease mental health symptoms associated with racial trauma experienced by Black, Indigenous, and people of color (BIPOC).
In this edited version of Roland Griffith’s very information talk on Psilocybin (original title “The science of psilocybin and its use to relieve suffering”) we take a look at the amazing positive effects achieved with this controversial substance.
Those of us who are professional counselors are perhaps most likely to recognize psychedelic drugs by their recreational or street names — acid, magic mushrooms, ecstasy — and to consider them to be drugs of abuse that may be dangerous to our clients.
"We met, married and formed a research team about twenty five years ago. This called upon a background of psychedelic drug invention and exploration of the previous twenty years, but it added a new dimension to this area of exploration.
3
Repeated intravenous (IV) ketamine infusions significantly reduce symptom severity in individuals with chronic post-traumatic stress disorder (PTSD) and the improvement is rapid and maintained for several weeks afterwards, according to a new study.
To continue customizing your FindCenter experience, create an account. It’s free!
Create an account to discover wisdom, save your favorite content, and connect with teachers and seekers.
IT’S FREE
If you already have an account, please log in.